Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1969 1
1971 2
1972 1
1973 1
2006 2
2007 1
2012 3
2013 3
2014 3
2015 2
2016 4
2017 1
2018 2
2019 3
2020 2
2021 7
2022 10
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
[Autism: psychoeducational intervention].
Bosa CA. Bosa CA. Braz J Psychiatry. 2006 May;28 Suppl 1:S47-53. doi: 10.1590/s1516-44462006000500007. Epub 2006 Jun 12. Braz J Psychiatry. 2006. PMID: 16791392 Free article. Review. Portuguese.
Anti-angiogenic approaches to malignant gliomas.
Soffietti R, Trevisan E, Bertero L, Bosa C, Ruda R. Soffietti R, et al. Among authors: bosa c. Curr Cancer Drug Targets. 2012 Mar;12(3):279-88. doi: 10.2174/156800912799277584. Curr Cancer Drug Targets. 2012. PMID: 22229250 Free article. Review.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
Safety of bevacizumab in patients with malignant gliomas: a systematic review.
Simonetti G, Trevisan E, Silvani A, Gaviani P, Botturi A, Lamperti E, Beecher D, Bertero L, Bosa C, Salmaggi A. Simonetti G, et al. Among authors: bosa c. Neurol Sci. 2014 Jan;35(1):83-9. doi: 10.1007/s10072-013-1583-6. Epub 2013 Nov 27. Neurol Sci. 2014. PMID: 24281944 Free article. Review.
Impact of COVID-19 lockdown on progressive multiple sclerosis patients.
Vercellino M, Bosa C, Alteno A, Schillaci V, Petracca M, Marasciulo S, Cavalla P. Vercellino M, et al. Among authors: bosa c. Neurol Sci. 2022 May;43(5):2943-2946. doi: 10.1007/s10072-022-05909-z. Epub 2022 Jan 24. Neurol Sci. 2022. PMID: 35075574 Free PMC article.
Acute and chronic synaptic pathology in multiple sclerosis gray matter.
Vercellino M, Marasciulo S, Grifoni S, Vallino-Costassa E, Bosa C, Pasanisi MB, Crociara P, Casalone C, Chiò A, Giordana MT, Corona C, Cavalla P. Vercellino M, et al. Among authors: bosa c. Mult Scler. 2022 Mar;28(3):369-382. doi: 10.1177/13524585211022174. Epub 2021 Jun 14. Mult Scler. 2022. PMID: 34124960
Antiangiogenic therapy of brain tumors: the role of bevacizumab.
Trevisan E, Bertero L, Bosa C, Magistrello M, Pellerino A, Rudà R, Soffietti R. Trevisan E, et al. Among authors: bosa c. Neurol Sci. 2014 Apr;35(4):507-14. doi: 10.1007/s10072-014-1627-6. Epub 2014 Jan 18. Neurol Sci. 2014. PMID: 24442487 Review.
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.
Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C, Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753829 Free PMC article.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Mult Scler. 2022 Jun;28(7):1034-1040. doi: 10.1177/13524585211035318. Epub 2021 Jul 30. Mult Scler. 2022. PMID: 34328824
Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud.
Marozio L, Cavalla P, Sottemano S, Vercellino M, Federici F, Cosma S, Peila C, Cresi F, Coscia A, Capobianco M, Bosa C, Schillaci V, Bellisario V, Migliaretti G, Benedetto C. Marozio L, et al. Among authors: bosa c. Mult Scler Relat Disord. 2022 Sep;65:104087. doi: 10.1016/j.msard.2022.104087. Epub 2022 Aug 1. Mult Scler Relat Disord. 2022. PMID: 35933740
44 results